ACE2 and COVID-19: If 19-23% of the population has constitutive ACE2 RNA deficiency predisposing to severe COVID-19, then that indicates that the remaining 54-58% of adults hospitalized with severe COVID-19 had blood ACE2 RNA suppressed by SARS-CoV-2 infection.